Join
Live feed
·
INSIDERFilingvia Quantisnow
Protagonist Therapeutics Inc. logo

Chief Development Officer Gupta Suneel exercised 205,450 shares at a strike of $8.40 and sold $5,635,430 worth of shares (122,628 units at $45.96), increasing direct ownership by 45% to 267,433 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTGX (Protagonist Therapeutics Inc.) and more on Quantisnow.